insitro pricing
insitro develops its own programs and earns from discovery partnerships rather than product sales. It has raised approximately $800 million in capital, including approximately $150 million from non dilutive pharma partnerships with Bristol Myers Squibb, Lilly and Gilead, and the Bristol Myers Squibb collaboration alone carried a total potential deal value over $2.1 billion.
How insitro pricing works
- Pricing model
- Multi target discovery partnership with upfront payments, research funding and milestones. No software license is sold.
insitro pricing against its alternatives
Published prices for insitro and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- IinsitroNot applicable
- VValo HealthNo published price
- IIsomorphic LabsNot applicable
- VVerge LabsPartnership structured, no list pricing
- EEikon TherapeuticsNot applicable
- XXtalPiNo published price
- IInsilico MedicineNo published price
- BBigHat BiosciencesNo published price
- XXaira TherapeuticsNot applicable
insitro pricing, answered
How much does insitro cost?
insitro does not publish a price. insitro develops its own programs and earns from discovery partnerships rather than product sales. It has raised approximately $800 million in capital, including approximately $150 million from non dilutive pharma partnerships with Bristol Myers Squibb, Lilly and Gilead, and the Bristol Myers Squibb collaboration alone carried a total potential deal value over $2.1 billion.